These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10821970)

  • 41. Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus.
    Lobigs M; Larena M; Alsharifi M; Lee E; Pavy M
    J Virol; 2009 Mar; 83(6):2436-45. PubMed ID: 19109382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice.
    Nickols B; Tretyakova I; Tibbens A; Klyushnenkova E; Pushko P
    Virology; 2017 Dec; 512():66-73. PubMed ID: 28938099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among Japanese encephalitis SA14-14-2 vaccinees in an endemic setting.
    Wang R; Fan D; Wang L; Li Y; Zhou H; Gao N; An J
    Infect Genet Evol; 2020 Nov; 85():104476. PubMed ID: 32736041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.
    Wang SY; Cheng XH; Li JX; Li XY; Zhu FC; Liu P
    Hum Vaccin Immunother; 2015; 11(6):1418-25. PubMed ID: 25915588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of cytoxan on immune response of Japanese encephalitis virus killed and live vaccines].
    Fang QA; Chen BQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):317-21. PubMed ID: 2561510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A chimeric live attenuated vaccine against Japanese encephalitis.
    Jones T
    Expert Rev Vaccines; 2004 Jun; 3(3):243-8. PubMed ID: 15176941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children.
    Ku CC; King CC; Lin CY; Hsu HC; Chen LY; Yueh YY; Chang GJ
    J Med Virol; 1994 Oct; 44(2):122-31. PubMed ID: 7852952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
    Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
    Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus.
    Saga R; Fujimoto A; Watanabe N; Matsuda M; Hasegawa M; Watashi K; Aizaki H; Nakamura N; Tajima S; Takasaki T; Konishi E; Kato T; Kohara M; Takeyama H; Wakita T; Suzuki R
    Sci Rep; 2016 Jun; 6():28688. PubMed ID: 27345289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine.
    Fan YC; Chen JM; Chen YY; Lin JW; Chiou SS
    Vet Microbiol; 2013 May; 163(3-4):248-56. PubMed ID: 23415032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis.
    Appaiahgari MB; Saini M; Rauthan M; Jyoti ; Vrati S
    Microbes Infect; 2006 Jan; 8(1):92-104. PubMed ID: 16126425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus.
    Ge FF; Qiu YF; Yang YW; Chen PY
    Arch Virol; 2007 Jan; 152(1):125-35. PubMed ID: 16862385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Product review on the JE vaccine IXIARO.
    Firbas C; Jilma B
    Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
    Pugachev KV; Mason PW; Shope RE; Frey TK
    Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
    Kim DS; Houillon G; Jang GC; Cha SH; Choi SH; Lee J; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Kim HS; Bang J; Naimi Z; Bosch-Castells V; Boaz M; Bouckenooghe A
    Hum Vaccin Immunother; 2014; 10(9):2656-63. PubMed ID: 25483480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.